Basal forebrain stimulation induces NGF secretion in ipsilateral parietal cortex via nicotinic receptor activation in adult, but not aged rats

Neuroscience Research

Volumn 63, Issue 2, 2009, Pages 122-128

  Hotta, Harumi ^a   Kagitani, Fusako ^a   Kondo, Masahiro ^a   Uchida, Sae ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Aging; Cerebral blood flow; Cerebral cortex; Microdialysis; Nerve growth factor; Nicotinic receptors; Nucleus basalis of Meynert

Indexed keywords

NERVE GROWTH FACTOR; NICOTINIC RECEPTOR;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN DEPTH STIMULATION; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; ELECTROSTIMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOREBRAIN; MALE; MICRODIALYSIS; NEOCORTEX; NEUROCHEMISTRY; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; ATROPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNCTIONAL LATERALITY; MALE; MECAMYLAMINE; MUSCARINIC ANTAGONISTS; NERVE GROWTH FACTOR; NICOTINIC ANTAGONISTS; PARIETAL LOBE; PROSENCEPHALON; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; REGIONAL BLOOD FLOW; TIME FACTORS;

EID: 58149510103     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.11.004     Document Type: Article

References (30)

1. Abiru Y., Katoh-Semba R., Nishio C., and Hatanaka H. High potassium enhances secretion of neurotrophic factors from cultured astrocytes. Brain Res. 809 (1998) 115-126
2. Araujo D.M., Lapchak P.A., Meaney M.J., Collier B., and Quirion R. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites. J. Neurosci. 10 (1990) 3069-3078
3. Biesold D., Inanami O., Sato A., and Sato Y. Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats. Neurosci. Lett. 98 (1989) 39-44
4. Birtsch C., Wevers A., Traber J., Maelicke A., Bloch W., and Schröder H. Expression of alpha 4-1 and alpha 5 nicotinic cholinoceptor mRNA in the aging rat cerebral cortex. Neurobiol. Aging 18 (1997) 335-342
5. Blöchl A., and Thoenen H. Characterization of nerve growth factor (NGF) release from hippocampal neurons: evidence for a constitutive and an unconventional sodium-dependent regulated pathway. Eur. J. Neurosci. 7 (1995) 1220-1228
6. Brigadski T., Hartmann M., and Lessmann V. Differential vesicular targeting and time course of synaptic secretion of the mammalian neurotrophins. J. Neurosci. 25 (2005) 7601-7614
7. Brown R.W., Perna M.K., Schaefer T.L., and Williams M.T. The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole. Synapse 59 (2006) 253-259
8. Bruno M.A., and Cuello A.C. Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 6735-6740
9. Cuello A.C., Bruno M.A., and Bell K.F.S. NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease. Curr. Alzheimer Res. 4 (2007) 351-358
10. Debeir T., Saragovi H.U., and Cuello A.C. A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 4067-4072
11. Furukawa S., Furukawa Y., Satoyoshi E., and Hayashi K. Regulation of nerve growth factor synthesis/secretion by catecholamine in cultured mouse astroglial cells. Biochem. Biophys. Res. Commun. 147 (1987) 1048-1054
12. Hotta H., Uchida S., and Kagitani F. Stimulation of the nucleus basalis of Meynert produces an increase in the extracellular release of nerve growth factor in the rat cerebral cortex. J. Physiol. Sci. 57 (2007) 383-387
13. Kimura A., Okada K., Sato A., and Suzuki H. Regional cerebral blood flow in the frontal, parietal and occipital cortices increases independently of systemic arterial pressure during slow walking in conscious rats. Neurosci. Res. 20 (1994) 309-315
14. Kurosawa M., Sato A., and Sato Y. Stimulation of the nucleus basalis of Meynert increases acetylcholine release in the cerebral cortex in rats. Neurosci. Lett. 98 (1989) 45-50
15. Lee T.H., Kato H., Kogure K., and Itoyama Y. Temporal profile of nerve growth factor-like immunoreactivity after transient focal cerebral ischemia in rats. Brain Res. 713 (1996) 199-210
16. Lindefors N., Ernfors P., Falkenberg T., and Persson H. Septal cholinergic afferents regulate expression of brain-derived neurotrophic factor and beta-nerve growth factor mRNA in rat hippocampus. Exp. Brain Res. 88 (1992) 78-90
17. Marksteiner J., Pirchl M., Ullrich C., Oberbauer H., Blasko I., Lederer W., Hinterhuber H., and Humpel C. Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties. Pharmacology 82 (2008) 214-220
18. Martínez-Rodríguez R., Toledano A., Álvarez M.I., Turégano L., Colman O., Rosés P., Gómez de Segura I., and De Miguel E. Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex. J. Neurosci. Res. 73 (2003) 708-716
19. Nishio T., Furukawa S., Akiguchi I., Oka N., Ohnishi K., Tomimoto H., Nakamura S., and Kimura J. Cellular localization of nerve growth factor-like immunoreactivity in adult rat brain: quantitative and immunohistochemical study. Neuroscience 60 (1994) 67-84
20. Nordberg A., Alafuzoff I., and Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res. 31 (1992) 103-111
21. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. (1998), Academic Press, San Diego
22. Pepeu G., and Giovannini M.G. Changes in acetylcholine extracellular levels during cognitive processes. Learn. Mem. 11 (2004) 21-27
23. Rattray M. Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease. Biol. Psychiatry 49 (2001) 185-193
24. Roßner S., Wörtwein G., Gu Z., Yu J., Schliebs R., Bigl V., and Perez-Polo J.R. Cholinergic control of nerve growth factor in adult rats: evidence from cortical cholinergic deafferentiation and chronic drug treatment. J. Neurochem. 69 (1997) 947-953
25. Sato A., and Sato Y. Cholinergic neural regulation of regional cerebral blood flow. Alzheimer Dis. Assoc. Disord. 9 (1995) 28-38
26. Seo H., Ferree A.W., and Isacson O. Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice. Eur. J. Neurosci. 15 (2002) 498-506
27. Stewart M., and Fox S.E. Two populations of rhythmically bursting neurons in rat medial septum are revealed by atropine. J. Neurophysiol. 61 (1989) 982-993
28. Uchida S., Kagitani F., Nakayama H., and Sato A. Effect of stimulation of nicotinic cholinergic receptors on cortical cerebral blood flow and changes in the effect during aging in anesthetized rats. Neurosci. Lett. 228 (1997) 203-206
29. Uchida S., Suzuki A., Kagitani F., and Hotta H. Effects of age on cholinergic vasodilation of cortical cerebral blood vessels in rats. Neurosci. Lett. 294 (2000) 109-112
30. Whittemore S.R., and Seiger A. The expression, localization and functional significance of beta-nerve growth factor in the central nervous system. Brain Res. Rev. 12 (1987) 439-464